Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study

PURPOSE: Valproic acid is an anticonvulsant that also inhibits histone deacetylase (HDAC), a property that could worsen pulmonary function in patients with chronic obstructive pulmonary disease (COPD). The clinical significance of this property is unknown. We therefore compared the risk of COPD exac...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoniou, Tony, Yao, Zhan, Camacho, Ximena, Mamdani, Muhammad M, Juurlink, David N, Gomes, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497617/
https://www.ncbi.nlm.nih.gov/pubmed/25656984
http://dx.doi.org/10.1002/pds.3761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497617/
https://www.ncbi.nlm.nih.gov/pubmed/25656984
http://dx.doi.org/10.1002/pds.3761

Ejemplares similares